TY - CONF T1 - COST-EFFECTIVENESS ANALYSIS OF CASPOFUNGIN VERSUS AMPHOTERICIN B, VORICONAZOLE, AND ANIDULAFUNGIN IN THE TREATMENT OF INVASIVE CANDIDIASIS JO - VALUE HEALTH PY - 2008/11/01 AU - Verheggen BG AU - Heeg BMS AU - Vos CBJ AU - Van Hout BA ED - VL - 11 IS - 6 SP - A437 EP - A437 Y2 - 2025/06/28 ER -